{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-25-000068","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.834339+00:00","generated_at":"2026-05-17T13:53:22.897216+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Kiora Pharmaceuticals furnishes updated investor presentation for H.C. Wainwright conference","bullets":["Filed 8-K on August 13, 2025 to disclose updated investor presentation (Exhibit 99.1).","Presentation prepared for H.C. Wainwright 5th Annual Ophthalmology Virtual Conference.","Company CFO Melissa Tosca signed the report as principal financial officer.","Data presented under Item 7.01 Regulation FD and not deemed filed for Exchange Act purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-25-000068","json":"https://secwatch.observer/filing/0001372514-25-000068.json","markdown":"https://secwatch.observer/filing/0001372514-25-000068.md","text":"https://secwatch.observer/filing/0001372514-25-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000068/0001372514-25-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000068/kprx-20250813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T13:53:22.897216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}